Date: 07 December 2018
A Greater Manchester site is leading the way with recruitment to a number of breast cancer clinical research studies.
The Oncology Research Hub at Wythenshawe Hospital, part of Manchester University NHS Foundation Trust (MFT), is the top UK recruiter to three open studies, and second highest recruiter to another.
The studies are on the National Institute for Health Research (NIHR) Clinical Research Network (CRN) portfolio, supported locally by CRN Greater Manchester.
The studies are:
TIP study: An MFT-sponsored study looking at a blood thinning drug called rivaroxaban to see if it can help women with early breast cancer. Wythenshawe Hospital is the top UK recruiting site with 21.
Margin Probe Device: An MFT-sponsored study looking at whether a new device called a MarginProbe can reduce the number of operations women need after breast conserving surgery. Wythenshawe Hospital is the top UK recruiting site with 57.
SERD study: A commercial study, sponsored by AstraZeneca, comparing the effects of AZD9496 vs Fulvestrant in the treatment of Primary Breast Cancer in postmenopausal women. Wythenshawe Hospital is the joint-top UK recruiting site with 5.
Primetime: A study to see if women who only have a very small risk of their breast cancer returning need to have radiotherapy after surgery. The study is sponsored by the Institute of Cancer Research (ICR). Wythenshawe Hospital is the second highest UK recruiting site with 43 and has met its four-year recruitment target in less than a year.
Angela Chrisopoulou, Oncology Research Hub Lead, Breast Research Office at Wythenshawe Hospital, said: “The team is performing extremely well across a number of Portfolio studies and is having great success with recruiting participants.
“Everyone is determined to ensure that these recruitment figures continue to rise as we strive to offer the opportunity to participate in clinical research to as many breast cancer patients as possible.”
Dr Manju Luckson, CRN GM Assistant Delivery Manager for Oncology, said: “We have a very strong working relationship with the research team at Wythenshawe Hospital and we work closely to ensure the targets for the team are met.”
You may also be interested in